Amberly Brown - Dissemin

All papers authored by Amberly Brown

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Patrick M. Grierson, Rama Suresh, Benjamin Tan, Katrina S. Pedersen, Manik Amin, Haeseong Park, Nikolaos A. Trikalinos, Jingxia Liu, Nicholas Boice, Amberly Brown

, Sapana Bansod, Andrea Wang-Gillam, Kian-Huat Lim

Supplementary Table 1 from A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy

Upload

Patrick M. Grierson, Rama Suresh, Benjamin Tan, Katrina S. Pedersen, Manik Amin, Haeseong Park, Nikolaos A. Trikalinos, Jingxia Liu, Nicholas Boice, Amberly Brown

, Sapana Bansod, Andrea Wang-Gillam, Kian-Huat Lim

Data from A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

, Rama Suresh, Albert C. Lockhart, Amberly Brown

, Marcus Breden, Jad I. Belle, John Herndon

, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Table S2 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

, Rama Suresh, Albert C. Lockhart, Amberly Brown

, Marcus Breden, Jad I. Belle, John Herndon

, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Data from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

, Rama Suresh, Albert C. Lockhart, Amberly Brown

, Marcus Breden, Jad I. Belle, John Herndon

, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Table S1 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

2022 Andrea Wang-Gillam

, Kian-Huat Lim

, Robert McWilliams

, Rama Suresh

, Albert C. Lockhart

, Amberly Brown

, Marcus Breden

, Jad I. Belle

, John Herndon

, Savannah J. Bogner

, Katrina Pedersen

, Benjamin Tan

, Nicholas Boice

, Abhi Acharya

, Mina Abdiannia

and 9 other authors

Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

This paper is made freely available by the publisher.

2017 Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, Andrea Wang-Gillam, Benjamin R. Tan, Manik Amin, Katrina S. Pedersen, Haeseong Park, Rama Suresh, Kian-Huat Lim, Emily Ratchford, Amberly Brown

, A. Craig Lockhart

Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer

Download from doi.org

2015 Manik Amin, Monica Dandona Desai, Kathryn Trinkaus, Amberly Brown

, Kian-Huat Lim, Andrea Wang-Gillam, Benjamin R. Tan, Joel Picus, Steven Sorscher, Maureen Highkin, Kimberly Lears, Lockhart Ac, Albert C. Lockhart

Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer.

Download from doi.org

2012 Jared Bruce, Laura Hancock, Brandon Roberg, Amberly Brown

, Erik Henkelman, Sharon Lynch

Impact of Armodafinil on Cognition in Multiple Sclerosis

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Amberly Brown